China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
CN |
Intrinsic Value
The intrinsic value of China National Medicines Corp Ltd (600511) under the Base Case is 45.19 CNY per share. Compared with the current market price of 27.7 CNY, the stock appears Undervalued by 39% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What China National Medicines Does
China National Medicines Corp Ltd is a Chinese healthcare company that sits in the middle of the drug supply chain. It buys prescription medicines, over-the-counter drugs, medical devices, and related health products from manufacturers and sells them onward to hospitals, pharmacies, clinics, and other healthcare buyers. It also helps move and store these products through its distribution and logistics network.
- Headquarters
- China CN
- Employees
- 3 024
- IPO date
- Nov 27, 2002
Revenue & Expenses Breakdown
China National Medicines Corp Ltd
Earnings Waterfall
China National Medicines Corp Ltd
The intrinsic value for China National Medicines Corp Ltd (600511) under the Base Case is 45.19 CNY.
Compared with the current market price of 27.7 CNY, the stock appears Undervalued by 39% .